Company news
Madrigal Pharmaceuticals, Inc. news in 2019
Madrigal Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.
Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock
December 9, 2019
Madrigal Pharmaceuticals Announces Pricing of Secondary Offering
December 9, 2019
Madrigal Pharmaceuticals Announces Publication in The Lancet of Positive Phase 2 Results for Resmetirom (MGL-3196) for the Treatment of Non-alcoholic Steatohepatitis (NASH)
November 10, 2019
Madrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and Highlights
November 5, 2019